Curofy
FDA Alert: FDA Clears Bevespi Aerosphere for COPD
The US Food and Drug Administration (FDA) has approved the first long-acting muscarinic antagonist/long-acting beta-2 agonist combination in a pressurized metered-dose inhaler (pMDI).
See this content immediately after install